Physician profile
Thomas Murickan
NPI 1033560875
$2,329.76
in general payments reported to CMS, 2019-2025
9 companies · $721 in 2025
The $721 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $202 · 2023: $25.49 · 2024: $1,382 · 2025: $721.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,393 · Food and Beverage: $727 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,392.55 |
| Food and Beverage | $726.58 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,188.23 | 2024 | |
| Organox LTD | $720.79 | 2025 | |
| Aroa Biosurgery Incorporated | $151.95 | 2024 | |
| Pfizer INC. | $113.68 | 2019 | |
| Z-Medica, LLC | $47.67 | 2019 | |
| Allergan, INC. | $40.54 | 2019 | |
| Davol INC. | $25.49 | 2023 | Phasix Mesh |
| Vifor Pharma, INC. | $24.15 | 2024 | Veltassa |
| Merck Sharp & Dohme LLC | $17.26 | 2024 | Prevymis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Murickan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.